Just won an award.....very Isable..(if you can put it that way)..another of Robbie Burns clever stock picks....decided myself to join in...not sure how high this could go but looking good at the moment !.

A few days historical.

http://www.sharecast.com/cgi-bin/sharecast/story.cgi?story_id=20427759 http://www.sharecast.com/cgi-bin/sharecast/story.cgi?story_id=20427759

Worth a read.....

http://www.bbc.co.uk/news/uk-scotland-scotland-business-19949157

A buy in this weeks shares publication. The retinal diagnostics specialist has boosted sales by 32% this year. Now with the US market accounting for 80% of sales of its new Daytona scanning machine, expect more growth.

Notice of Results
RNS
RNS Number : 6922P
Optos plc
29 October 2012









OPTOS PLC



NOTICE OF PRELIMINARY RESULTS





LONDON, UK, 29 October 2012 - Optos plc (LSE: OPTS) the leading retinal imaging company, will announce its preliminary results for the year ended 30 September 2012 on Wednesday, 21 November 2012.



A presentation for analysts will be held at 9.30am at the offices of FTI Consulting, Holborn Gate, 26 Southampton Buildings, London WC2A 1PB.





Enquiries:



FTI Consulting
Tel: +44 (0) 20 7831 3113

Mo Noonan

OPTS OPTOS

Brokers have certainly got very
bullish SP targets in place

Optos Broker Views

Date Broker Recommendation Price Old target price New target price Notes

15 Oct Canaccord Genuity Buy 181.50 306.00 306.00 Retains
15 Oct Investec Hold 181.50 202.00 202.00 Retains
15 Oct Numis Buy 181.50 300.00 300.00 Reiterates
15 Oct Panmure Gordon Buy 181.50 230.00 320.00 Upgrades
15 Oct Jefferies International Buy 181.50 270.00 280.00 Retains

NORWICH & PETERBOROUGH BUILDING SOCIETY

And we can see from hemscott
the P/E is hardly demanding going forward....

INVESTMENT RATIOS
2011 (A) 2012 (E) 2013 (E)

EBITDA £41.34m £29.40m £27.55m
EBIT £25.36m £14.77m £17.37m
Dividend Yield % % %
Dividend Cover x x x
PER 5.08x 12.64x 10.44x
PEG 0.04f -0.21f 0.50f
Net Asset Value PS 64.56p 68.58p 82.16p

Results wed coming.

Worth having a look at this historical link...

http://www.thisismoney.co.uk/money/investing/article-2220663/MIDAS-SHARE-TIPS-Great-outlook-eye-imaging-firm-Optos.html

OPTS OPTOS

TECHINVEST.......

I noticed in the free jul issue of techinvest that they made this a nap tip for 2nd part of the year at.......

190p expressing "no clear reasons why the price has underperformed recently". They also bought it into their portfolio at 230p in may12.

OPTS OPTOS

Just a reminder of the last trading
statement........

OPTOS PLC

TRADING UPDATE
15/oct 2012


Daytona Delivers



LONDON, UK, 15 October 2012 - Optos plc (LSE: OPTS), the leading medical retinal imaging company, today provides a trading update for the financial year ended 30 September 2012, ahead of the planned publication of its Preliminary Results on 21 November 2012. All figures are unaudited.



Following strong sales in the last quarter, revenues for the year to 30 September 2012 are expected to exceed $190m, ahead of market expectations.

http://www.investegate.co.uk/optos-plc-(opts)/rns/trading-statement/201210150700066486O/

OPT OPTOS

Just out....

16 Nov Optos PLC OPTS Panmure Gordon Buy 185.75 184.75 320.00 320.00 Retains

SP TARGET a whopping 320p.

OPT OPTOS

just out another reco

16 Nov Optos PLC OPTS Jefferies International Buy 185.50 184.75 280.00 280.00 Retains

280p SP Tatget.

Historical item on OPTS

http://www.sharecast.com/cgi-bin/sharecast/story.cgi?story_id=20441825

OPT OPTOS

Remember results wed.

Article linked to them below.


Strong end to the year for Optos
Mon 15 Oct 2012

OPTS - Optos

Latest Prices
Name Price %
Optos 179.50p -2.84%

FTSE All-Share 2,940 -0.98%
FTSE Small Cap 3,186 -0.79%
techMARK 2,024 -0.87%
techMARK 100 2,351 -0.65%
Health Care Equipment & Services 3,634 -0.77%

LONDON (SHARECAST) - Optos saw shares rise strongly on Monday morning after saying that both turnover and operating profit for the year ending September 30th was ahead of market expectations.

The ophthalmology equipment maker reported that, following strong sales in the last quarter, “revenues are expected to exceed $190m”, ahead of consenus expectations of $183m, with operating profit expected to be “slightly above market consensus” of $22.3m.

Manufacture of its latest product range, the Daytona, has reached current planned capacity in the last quarter, allowing the full year (ending 2012) order backlog to be fully cleared and resulting in an installed base of 329 devices at the end of September 2012.

As stated in its third-quarter interim management statement, the company expects “gross margins to improve during full year 2013 as Daytona volumes increase”.

Chief Executive Officer Roy Davis commented: “I am delighted with the company’s achievements this year and in particular, the manufacturing scale-up and market roll-out of Daytona.

"The reaction to this instrument has been very positive and I am excited by the opportunities it brings to the business. Our near-term focus is to drive sales of Daytona in all our key markets and to continue our success with the 200Tx instrument in the ophthalmology market.”


Broker reaction


Broker reaction to the update has been equally positive. Numis has reiterated its “buy” rating and 300p share price target, while Jefferies, which also has a “buy” rating, has raised its price target to 280p from 270p.

Meanwhile, Panmure Gordon has upgraded its rating from 'hold' to 'buy', saying that Optos "should be a core holding to investors looking to have healthcare in their portfolio". The broker raised its target price for the shares from 230p to 320p.

http://www.sharecast.com/cgi-bin/sharecast/story.cgi?story_id=20427759

Lets hope this turns direction with some good news

Last trading statement....

results wed tomorrow........

http://www.sharecast.com/cgi-bin/sharecast/story.cgi?story_id=20427759

Losing ground ?

Yeap across road at iii guy reckons its MMs storing stock for good results tomorrow.?.

Been a few recent days where demand stronger than supply but SP dropped. he maybe right he maybe wrong.

We'l know in the morning, fingers crossed.

Thanks for that update g.

Looks like it moves fast on good news looking back to March/April .

OPTOS PLC

Preliminary Results FY12

Highlights



Strong financial performance ahead of expectations

- Revenue and other operating income(1) up 37% to $196.4m

- 15% underlying revenue growth(2)

- $21.0m revenue from Daytona, our next generation desktop retinal imaging device, with 329 devices installed this year

- Timing of manufacturing scale up of Daytona contributed to a fall in gross margin from 64% to 57%(3)

- In a year of significant investment, profit before tax and exceptional items increased 16% to $26.3m versus $22.7m last year

- Diluted EPS post-exceptional was 25% lower at 23.9 cents from 31.8 cents reflecting acquisition-related charges, and for the first time, a net tax charge on profits

- Investment in the business, and the increase in self-funded finance leases, contributed to a cash decrease of $3.6m in the year

- A three year bank facility of $30m was taken on to finance the OPKO acquisition, contributing to a net debt increase to $47.9m



Increased geographical reach

- Our two geographic segments both grew in double digits

- North American sales grew 26% to $147.8m

- International sales grew 85% to $48.6m

- Strengthened positions in Europe, Middle East and Asia



Investment in the product range

- Completion of manufacturing scale-up and market roll-out of Daytona

- Continued progress on the development project to combine our ultra wide-field retinal imaging technology with ocular coherence tomography ("OCT") into a single device



Accelerated growth in ophthalmology

- Over 320 200Tx devices installed globally, including into key ophthalmology centres in the USA, Germany, Jeddah, Dubai, Abu Dhabi, as well as Japan





http://www.moneyam.com/action/news/showArticle?id=4488583